Lucid Diagnostics joins Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

LUCD•2026-11-04

Lucid Diagnostics will attend the forum in New York City on Nov. 11, 2026. CEO Lishan Aklog will join a 3:30 p.m. ET panel, and Aklog and CFO Dennis McGrath will hold investor meetings.

1. Forum participation

Lucid Diagnostics will attend Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum in New York City on Nov. 11, 2026. Chairman and CEO Lishan Aklog will join an oncology diagnostics reimbursement panel at 3:30 p.m. ET; the panel will not be webcast.

2. Investor meetings

Aklog and Chief Financial Officer Dennis McGrath will also hold one-on-one investor meetings.

Lucid Diagnostics joins Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

1. Forum participation

2. Investor meetings

Related News

Evaxion reports new data supporting EVX-04 vaccine for acute myeloid leukemia

Guided Therapeutics provides update on its cervical cancer screening study with Türkiye’s Ministry of Health

Marsh private markets AUM rises to $75 billion after AltamarCAM acquisition

TD SYNNEX report finds AI investment outpaces revenue gains among technology resellers

SeaStar Medical to report third-quarter financial results